Opthea

Large layoffs of employees Wooden figures of people going to the exit

Opthea lays off 65% of staff after back-to-back phase 3 flops

Days after two flops sank an eye disease asset, the biotech revealed plans to lay off 65% of its staff and operate with a skeleton crew to save money.

Nick Paul Taylor Apr 10, 2025 7:52am

Opthea scraps wet AMD program after eye drug loses to Lucentis

Mar 31, 2025 6:55am

Opthea's eye disease drug defeated by Eylea in phase 3

Mar 24, 2025 5:24am

Lilly goes all-in on AI with new exec position—Chutes & Ladders

Oct 11, 2024 8:30am

Cue Biopharma queues up J&J vet as CBO—Chutes & Ladders

Sep 13, 2024 8:30am

Former BMS R&D chief Vessey jumping to Flagship—Chutes & Ladders

Jul 14, 2023 9:30am